Literature DB >> 26812091

Comparative Assessment of Glycosylation of a Recombinant Human FSH and a Highly Purified FSH Extracted from Human Urine.

Hong Wang1, Xi Chen2, Xiaoxi Zhang3, Wei Zhang3, Yan Li4, Hongrui Yin1, Hong Shao1, Gang Chen1.   

Abstract

Glycosylation is an important PTM and is critical for the manufacture and efficacy of therapeutic glycoproteins. Glycan significantly influences the biological properties of human follicle-stimulating hormone (hFSH). Using a glycoproteomic strategy, this study compared the glycosylation of a putative highly purified FSH (uhFSH) obtained from human urine with that of a recombinant human FSH (rhFSH) obtained from Chinese hamster ovary (CHO) cells. Intact and subunit masses, N-glycans, N-glycosylation sites, and intact N- and O-glycopeptides were analyzed and compared by mass spectrometry. Classic and complementary analytical methods, including SDS-PAGE, isoelectric focusing, and the Steelman-Pohley bioassay were also employed to compare their intact molecular weights, charge variants, and specific activities. Results showed that highly sialylated, branched, and macro-heterogeneity glycans are predominant in the uhFSH compared with those in rhFSH. The O-glycopeptides of both hFSHs, which have not been described previously, were characterized herein. A high degree of heterogeneity was observed in the N-glycopeptides of both hFSHs. The differences in glycosylation provide useful information in elucidating and in further investigation the critical glycan structures of hFSH.

Entities:  

Keywords:  follicle-stimulating hormone; glycosylation; mass spectrometry; rhFSH; uhFSH

Mesh:

Substances:

Year:  2016        PMID: 26812091     DOI: 10.1021/acs.jproteome.5b00921

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  7 in total

Review 1.  Follicle-Stimulating Hormone Glycobiology.

Authors:  George R Bousfield; David J Harvey
Journal:  Endocrinology       Date:  2019-06-01       Impact factor: 4.736

2.  Evaluation of in vivo bioactivities of recombinant hypo- (FSH21/18) and fully- (FSH24) glycosylated human FSH glycoforms in Fshb null mice.

Authors:  Huizhen Wang; Jacob May; Viktor Butnev; Bin Shuai; Jeffrey V May; George R Bousfield; T Rajendra Kumar
Journal:  Mol Cell Endocrinol       Date:  2016-08-22       Impact factor: 4.102

3.  Oligomannosidic glycans at Asn-110 are essential for secretion of human diamine oxidase.

Authors:  Elisabeth Gludovacz; Daniel Maresch; Leonor Lopes de Carvalho; Verena Puxbaum; Laurenz J Baier; Leander Sützl; Gabriela Guédez; Clemens Grünwald-Gruber; Barbara Ulm; Sophie Pils; Robin Ristl; Friedrich Altmann; Bernd Jilma; Tiina A Salminen; Nicole Borth; Thomas Boehm
Journal:  J Biol Chem       Date:  2017-11-29       Impact factor: 5.486

Review 4.  Quantitative clinical glycomics strategies: A guide for selecting the best analysis approach.

Authors:  Milani W Patabandige; Leah D Pfeifer; Hanna T Nguyen; Heather Desaire
Journal:  Mass Spectrom Rev       Date:  2021-02-10       Impact factor: 9.011

5.  Comparative pharmacology of a new recombinant FSH expressed by a human cell line.

Authors:  Wolfgang Koechling; Daniel Plaksin; Glenn E Croston; Janni V Jeppesen; Kirsten T Macklon; Claus Yding Andersen
Journal:  Endocr Connect       Date:  2017-04-27       Impact factor: 3.335

6.  FSH dosage effect on conventional sperm parameters: a meta-analysis of randomized controlled studies.

Authors:  Rossella Cannarella; Sandro La Vignera; Rosita A Condorelli; Laura M Mongioì; Aldo E Calogero
Journal:  Asian J Androl       Date:  2020 May-Jun       Impact factor: 3.285

7.  Pregnancy and neonatal outcomes in fresh and frozen cycles using blastocysts derived from ovarian stimulation with follitropin delta.

Authors:  Jon Havelock; Anna-Karina Aaris Henningsen; Bernadette Mannaerts; Joan-Carles Arce
Journal:  J Assist Reprod Genet       Date:  2021-07-13       Impact factor: 3.412

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.